{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:24:29Z","timestamp":1789431869819,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Targeted protein degradation (TPD) mediated by proteolysis-targeting chimeras (PROTACs) has emerged as a powerful therapeutic strategy, enabling the catalytic and selective elimination of disease-relevant proteins via the ubiquitin\u2013proteasome system. Despite their ability to overcome drug resistance and address traditionally undruggable targets, the structural complexity and vast chemical diversity of PROTACs present challenges for systematic analysis and rational design. Here, we present a systematic unsupervised machine-learning framework that represents the first large-scale similarity-driven clustering and scaffold-centric analysis of the PROTAC chemical space, to comprehensively characterize the structural, functional, and physicochemical landscape of PROTAC molecules and to support data-driven lead optimization and next-generation degrader design. An initial dataset of 9,380 compounds was curated from the publicly available PROTACs Database (PROTAC-DB 3.0), followed by rigorous standardization and filtering, resulting in 6,113 unique, chemically valid compounds. The chemical space was explored using a multi-step computational pipeline involving dimensionality reduction and a comparative evaluation of diverse clustering algorithms. Among the evaluated approaches, a refined clustering strategy demonstrated superior performance in partitioning the dataset into structurally coherent groups. Structural analysis revealed a pronounced convergence around canonical PROTAC architectures, characterized by conserved E3 ligase-binding motifs, diverse target-binding frameworks, and heterogeneous linker designs. Functional group profiling and physicochemical analysis further demonstrated that these compounds predominantly occupy a specialized chemical space beyond traditional drug-like limits, marked by high molecular weight and substantial conformational flexibility. Collectively, these findings provide data-driven design guidance for PROTAC optimization by highlighting frequent scaffold architectures and preferred property ranges, thereby informing the development of next-generation degraders.<\/jats:p>","DOI":"10.1038\/s41598-026-53215-x","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:46:36Z","timestamp":1781073996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural diversity and chemical space analysis of a PROTAC database using unsupervised machine learning"],"prefix":"10.1038","volume":"16","author":[{"given":"Ashutosh","family":"Kharwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Marb\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Medina-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Vel\u00e1zquez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"9","key":"53215_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A. L. & Groom, C. R. The druggable genome Nat. Rev. Drug Discovery 1(9):727 (2002).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"8","key":"53215_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nchembio.1867","volume":"11","author":"CH Arrowsmith","year":"2015","unstructured":"Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11(8):536 (2015).","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"53215_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. MYC on the path to cancer Cell 149(1):22 (2012).","journal-title":"Cell"},{"key":"53215_CR4","doi-asserted-by":"crossref","unstructured":"Sakamoto, K. M. et al. Protacs: Chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation. Proc. Natl. Acad. Sci. 98(15):8554 (2001).","DOI":"10.1073\/pnas.141230798"},{"issue":"9","key":"53215_CR5","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1002\/anie.201307761","volume":"53","author":"DL Buckley","year":"2014","unstructured":"Buckley, D. L. & Crews, C. M. Small\u2010molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system Angew. Chem. Int. Ed. 53(9):2312 (2014).","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"53215_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","volume":"181","author":"GM Burslem","year":"2020","unstructured":"Burslem, G. M. & Crews, C. M. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery Cell 181(1):102 (2020).","journal-title":"Cell"},{"key":"53215_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","volume":"174","author":"TK Neklesa","year":"2017","unstructured":"Neklesa, T. K., Winkler, J. D. & Crews, C. M. Targeted protein degradation by PROTACs Pharmacol. Ther. 174:138 (2017).","journal-title":"Pharmacol. Ther."},{"issue":"6241","key":"53215_CR8","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","volume":"348","author":"GE Winter","year":"2015","unstructured":"Winter, G. E. et al. Winter, G. E. et al. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 348(6241):1376 (2015).","journal-title":"Science"},{"issue":"8","key":"53215_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson, D. P. et al. Catalytic in vivo protein knockdown by small-molecule PROTACs Nat. Chem. Biol. 11(8):611 (2015).","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"53215_CR10","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"K Li","year":"2022","unstructured":"Li, K. & Crews, C. M. PROTACs: past, present and future. Chem. Soc. Rev. 51(12):5214 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"53215_CR11","doi-asserted-by":"crossref","unstructured":"Fisher, S. L. & Phillips, A. J. Targeted protein degradation and the enzymology of degraders. Curr. Opinion Chem. Biol. 44:47 (2018).","DOI":"10.1016\/j.cbpa.2018.05.004"},{"issue":"2","key":"53215_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/acs.jmedchem.7b01272","volume":"61","author":"I Churcher","year":"2018","unstructured":"Churcher, I. Protac-induced protein degradation in drug discovery: breaking the rules or just making new ones? J. Med. Chem. 61(2):444 (2018).","journal-title":"J. Med. Chem."},{"issue":"2","key":"53215_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","volume":"16","author":"AC Lai","year":"2017","unstructured":"Lai, A. C. & Crews, C. M. Induced protein degradation: an emerging drug discovery paradigm. Nat. Rev. Drug Discovery 16(2):101 (2017).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"13","key":"53215_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bmcl.2019.04.030","volume":"29","author":"SD Edmondson","year":"2019","unstructured":"Edmondson, S. D., Yang, B. & Fallan, C. Proteolysis targeting chimeras (PROTACs) in \u2018beyond rule-of-five\u2019chemical space: Recent progress and future challenges. Bioorg. Med. Chem. Lett. 29(13):1555 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"53215_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nchembio.2329","volume":"13","author":"MS Gadd","year":"2017","unstructured":"Gadd, M. S. et al. Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat. Chem. Biol. 13(5):514 (2017).","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"53215_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","volume":"18","author":"M Schapira","year":"2019","unstructured":"Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discovery 18(12):949 (2019).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"3","key":"53215_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","volume":"62","author":"JM Sasso","year":"2022","unstructured":"Sasso, J. M. et al. Molecular glues: the adhesive connecting targeted protein degradation to the clinic Biochemistry 62(3):601 (2022).","journal-title":"Biochemistry"},{"issue":"3","key":"53215_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discovery 21(3):181 (2022).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"4","key":"53215_CR19","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1021\/acs.jmedchem.3c01007","volume":"67","author":"DW Robbins","year":"2024","unstructured":"Robbins, D. W. et al. Discovery and preclinical pharmacology of NX-2127, an orally bioavailable degrader of Bruton\u2019s tyrosine kinase with immunomodulatory activity for the treatment of patients with B cell malignancies. J. Med. Chem. 67(4):2321 (2024).","journal-title":"J. Med. Chem."},{"issue":"1","key":"53215_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-025-01753-8","volume":"18","author":"D Mahadevan","year":"2025","unstructured":"Mahadevan, D. et al. First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed\/refractory solid malignancies. J. Hematol. Oncol. 18(1):98 (2025).","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"53215_CR21","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1021\/acs.jmedchem.7b00717","volume":"61","author":"DA DeGoey","year":"2017","unstructured":"DeGoey, D. A., Chen, H-J., Cox, P. B. & Wendt, M. D. Beyond the rule of 5: lessons learned from AbbVie\u2019s drugs and compound collection: miniperspective. J. Med. Chem. 61(7):2636 (2017).","journal-title":"J. Med. Chem."},{"issue":"9","key":"53215_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","volume":"21","author":"BC Doak","year":"2014","unstructured":"Doak, B. C., Over, B., Giordanetto, F. & Kihlberg, J. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem. Biol. 21(9):1115 (2014).","journal-title":"Chem. Biol."},{"issue":"3","key":"53215_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acschembio.9b00092","volume":"14","author":"MJ Roy","year":"2019","unstructured":"Roy, M. J. et al. SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate. ACS Chem. Biol. 14(3):361 (2019).","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"53215_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41467-018-08027-7","volume":"10","author":"BE Smith","year":"2019","unstructured":"Smith, B. E. et al. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat. Commun. 10(1):131 (2019).","journal-title":"Nat. Commun."},{"issue":"3","key":"53215_CR25","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1002\/mco2.290","volume":"4","author":"X Han","year":"2023","unstructured":"Han, X. & Sun, Y. PROTACs: A novel strategy for cancer drug discovery and development. MedComm 4(3):e290 (2023).","journal-title":"MedComm"},{"issue":"1","key":"53215_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41467-017-00954-1","volume":"8","author":"C Maniaci","year":"2017","unstructured":"Maniaci, C. et al. Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation. Nat. Commun. 8(1):830 (2017).","journal-title":"Nat. Commun."},{"issue":"12","key":"53215_CR27","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.bmc.2019.02.048","volume":"27","author":"M Girardini","year":"2019","unstructured":"Girardini, M., Maniaci, C., Hughes, S. J., Testa, A. & Ciulli, A. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs. Bioorg. Med. Chem. 27(12):2466 (2019).","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"53215_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-020-0594-x","volume":"16","author":"C Mayor-Ruiz","year":"2020","unstructured":"Mayor-Ruiz, C. et al. Rational discovery of molecular glue degraders via scalable chemical profiling. Nat. Chem. Biol. 16(11):1199 (2020).","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"53215_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s42256-022-00527-y","volume":"4","author":"S Zheng","year":"2022","unstructured":"Zheng, S. et al. Accelerated rational PROTAC design via deep learning and molecular simulations. Nat. Mach. Intell. 4(9):739 (2022).","journal-title":"Nat. Mach. Intell."},{"issue":"10","key":"53215_CR30","doi-asserted-by":"publisher","first-page":"101062","DOI":"10.1016\/j.xcrp.2022.101062","volume":"3","author":"X Han","year":"2022","unstructured":"Han, X. & Sun, Y. Strategies for the discovery of oral PROTAC degraders aimed at cancer therapy. Cell. Rep. Phys. Sci. 3(10):101062 (2022).","journal-title":"Cell. Rep. Phys. Sci."},{"issue":"D1","key":"53215_CR31","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45(D1):D945 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"53215_CR32","doi-asserted-by":"publisher","first-page":"D1510","DOI":"10.1093\/nar\/gkae768","volume":"53","author":"J Ge","year":"2025","unstructured":"Ge, J. et al. PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters. Nucleic Acids Res. 53(D1):D1510 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"53215_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 28(1):31 (1988).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"53215_CR34","doi-asserted-by":"crossref","unstructured":"Mitl\u00f6hner, J., Neumaier, S., Umbrich, J. & Polleres, A. Characteristics of open data CSV files. IEEE :72","DOI":"10.1109\/OBD.2016.18"},{"issue":"31.10","key":"53215_CR35","first-page":"5281","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum, G. RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum 8(31.10):5281 (2013).","journal-title":"Greg Landrum"},{"issue":"1\u201379","key":"53215_CR36","first-page":"4","volume":"1","author":"G Landrum","year":"2013","unstructured":"Landrum, G. RDKit documentation. Release 1(1\u201379):4 (2013).","journal-title":"Release"},{"issue":"7545","key":"53215_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/bmj.332.7545.833","volume":"332","author":"MJ Brown","year":"2006","unstructured":"Brown, M. J. Hypertension and ethnic group. BMJ 332 (7545), 833\u2013836 (2006).","journal-title":"BMJ"},{"issue":"3","key":"53215_CR38","first-page":"241","volume":"1","author":"P Willett","year":"2011","unstructured":"Willett, P. Similarity\u2010based data mining in files of two\u2010dimensional chemical structures using fingerprint measures of molecular resemblance. Wiley Interdisciplinary Reviews: Data Min. Knowl. Discovery. 1 (3), 241\u2013251 (2011).","journal-title":"Wiley Interdisciplinary Reviews: Data Min. Knowl. Discovery"},{"issue":"8","key":"53215_CR39","doi-asserted-by":"publisher","first-page":"085002","DOI":"10.1289\/EHP14001","volume":"132","author":"K Mansouri","year":"2024","unstructured":"Mansouri, K., Taylor, K., Auerbach, S., Ferguson, S., Frawley, R., Hsieh, J. H., \u2026 & Sutherland, V. Unlocking the potential of clustering and classification approaches: navigating supervised and unsupervised chemical similarity. Environ. Health Perspect. 132(8):085002 (2024).","journal-title":"Environ. Health Perspect."},{"key":"53215_CR40","unstructured":"Burkardt, J. Virginia Tech, Advanced Research Computing, Interdisciplinary Center for Applied Mathematics 5 (2009)."},{"key":"53215_CR41","doi-asserted-by":"crossref","unstructured":"Nielsen, F. Introduction to HPC with MPI for Data Science 195 (Springer, 2016).","DOI":"10.1007\/978-3-319-21903-5_8"},{"issue":"11","key":"53215_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21105\/joss.00205","volume":"2","author":"L McInnes","year":"2017","unstructured":"McInnes, L., Healy, J. & Astels, S. Hierarchical density based clustering. J. Open. Source Softw. 2(11):205 (2017).","journal-title":"J. Open. Source Softw."},{"key":"53215_CR43","doi-asserted-by":"publisher","first-page":"1382319","DOI":"10.3389\/fchem.2024.1382319","volume":"12","author":"XTD Tran","year":"2024","unstructured":"Tran, X. T. D. et al. Integration of the Butina algorithm and ensemble learning strategies for the advancement of a pharmacophore ligand-based model: an in silico investigation of apelin agonists. Front. Chem. 12, 1382319 (2024).","journal-title":"Front. Chem."},{"issue":"3","key":"53215_CR44","first-page":"272","volume":"8","author":"R Ibraimoh","year":"2024","unstructured":"Ibraimoh, R. & Aderoba, A. Comparison of K-Means and HDBSCAN clustering approaches to enhance marketing strategies. Iconic Res. Eng. J. 8 (3), 272 (2024).","journal-title":"Iconic Res. Eng. J."},{"issue":"1","key":"53215_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13321-015-0069-3","volume":"7","author":"D Bajusz","year":"2015","unstructured":"Bajusz, D., R\u00e1cz, A. & H\u00e9berger, K. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J. Cheminform. 7(1):20 (2015).","journal-title":"J. Cheminform."},{"issue":"1","key":"53215_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13321-016-0186-7","volume":"8","author":"J Velkoborsky","year":"2016","unstructured":"Velkoborsky, J. & Hoksza, D. Scaffold analysis of PubChem database as background for hierarchical scaffold-based visualization. J. Cheminform. 8(1):74 (2016).","journal-title":"J. Cheminform."},{"issue":"11","key":"53215_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41573-022-00505-4","volume":"21","author":"DM Mitrea","year":"2022","unstructured":"Mitrea, D. M., Mittasch, M., Gomes, B. F., Klein, I. A. & Murcko, M. A. Modulating biomolecular condensates: A novel approach to drug discovery. Nat. Rev. Drug Discovery 21(11):841 (2022).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"16","key":"53215_CR48","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1021\/acs.jcim.5c00334","volume":"65","author":"Y Buehler","year":"2025","unstructured":"Buehler, Y. & Reymond, J-L. A view on molecular complexity from the GDB chemical space. J. Chem. Inf. Model. 65(16):8405 (2025).","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"53215_CR49","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/ci9803381","volume":"39","author":"D Butina","year":"1999","unstructured":"Butina, D. Unsupervised data base clustering based on daylight\u2019s fingerprint and Tanimoto similarity: A fast and automated way to cluster small and large data sets. J. Chem. Inf. Comput. Sci. 39(4):747 (1999).","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"15","key":"53215_CR50","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis, G. W. & Murcko, M. A. The properties of known drugs. 1. Molecular frameworks J. Med. Chem. 39(15):2887 (1996).","journal-title":"J. Med. Chem."},{"key":"53215_CR51","doi-asserted-by":"crossref","unstructured":"Kogej, T., Kannas, C., Genheden, S., Caldeweyher, E. & Kabeshov, M. SMARTS-RX: a SMARTS-based representation of chemical functions for reactivity analysis. J. Cheminform. (2025).","DOI":"10.26434\/chemrxiv-2025-gw23n"},{"issue":"6","key":"53215_CR52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.gsf.2017.05.002","volume":"8","author":"CJ Spencer","year":"2017","unstructured":"Spencer, C. J., Yakymchuk, C. & Ghaznavi, M. Visualising data distributions with kernel density estimation and reduced chi-squared statistic. Geosci. Front. 8(6):1247 (2017).","journal-title":"Geosci. Front."},{"issue":"11","key":"53215_CR53","doi-asserted-by":"publisher","first-page":"2200116","DOI":"10.1002\/minf.202200116","volume":"41","author":"JL Medina-Franco","year":"2022","unstructured":"Medina-Franco, J. L., Ch\u00e1vez\u2010Hern\u00e1ndez, A. L., L\u00f3pez\u2010L\u00f3pez, E. & Sald\u00edvar\u2010Gonz\u00e1lez, F. I. Chemical multiverse: An expanded view of chemical space Mol. Inf. 41(11):2200116 (2022).","journal-title":"Mol. Inf."},{"key":"53215_CR54","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J. & Melville, J. Uniform manifold approximation and projection for dimension reduction. arXiv preprint arXiv:180203426 (2018).","DOI":"10.21105\/joss.00861"},{"key":"53215_CR55","doi-asserted-by":"crossref","unstructured":"Hetland, M. L. & Nelli, F. Activity 1: Data Analysis with Pandas, Matplotlib, and Seaborn 487 (From Novice to Professional: Springer,, 2024).","DOI":"10.1007\/979-8-8688-0196-9_25"},{"issue":"10","key":"53215_CR56","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1039\/C9MD00272C","volume":"10","author":"HJ Maple","year":"2019","unstructured":"Maple, H. J., Clayden, N., Baron, A., Stacey, C. & Felix, R. Developing degraders: principles and perspectives on design and chemical space MedChemComm 10(10):1755 (2019).","journal-title":"MedChemComm"},{"issue":"14","key":"53215_CR57","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1021\/jm100112j","volume":"53","author":"C Bissantz","year":"2010","unstructured":"Bissantz, C., Kuhn, B. & Stahl, M. A medicinal chemist\u2019s guide to molecular interactions. J. Med. Chem. 53(14):5061 (2010).","journal-title":"J. Med. Chem."},{"issue":"21","key":"53215_CR58","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1002\/anie.201007560","volume":"50","author":"LM Salonen","year":"2011","unstructured":"Salonen, L. M., Ellermann, M. & Diederich, F. Aromatic rings in chemical and biological recognition: Energetics and structures. Angew Chem. Int. Ed. Engl. 50(21):4808 (2011).","journal-title":"Angew Chem. Int. Ed. Engl."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53215-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:05:54Z","timestamp":1787569554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53215-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53215-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26372"}}